Search Results - "Lashinger, L M"

Obesity and Resistance to Cancer Chemotherapy: Interacting Roles of Inflammation and Metabolic Dysregulation by Lashinger, L M, Rossi, E L, Hursting, S D

“…The prevalence of obesity, an established risk factor for many chronic diseases, including several types of cancer, has risen steadily over the past four…”
Get full text

The acute effects of time-of-day-dependent high fat feeding on whole body metabolic flexibility in mice by Joo, J, Cox, C C, Kindred, E D, Lashinger, L M, Young, M E, Bray, M S

“…Background: Both circadian disruption and timing of feeding have important roles in the development of metabolic disease. Despite growing acceptance that the…”
Get full text

Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research by Hursting, Stephen D., Smith, Sarah M., Lashinger, Laura M., Harvey, Alison E., Perkins, Susan N.

“…Calorie restriction (CR) is arguably the most potent, broadly acting dietary regimen for suppressing the carcinogenesis process, and many of the key studies in…”
Get full text

Bortezomib abolishes tumor necrosis factor-related apoptosis- inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells by LASHINGER, Laura M, KEYI ZHU, WILLIAMS, Simon A, SHRADER, Marissa, DINNEY, Colin P. N, MCCONKEY, David J

“…Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor family of cytokines that induces apoptosis in some…”
Get full text

Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts by Raut, Chandrajit P., Nawrocki, Steffan, Lashinger, Laura M., Davis, Darren W., Khanbolooki, Sanaz, Xiong, Henry, Ellis, Lee M., McConkey, David J.

“…Previous studies suggest that antagonists of cyclooxygenases 1 and 2 (COX-1, -2) inhibit angiogenesis in tumor xenografts, but the molecular mechanisms…”
Get full text